Skip to main content
. 2017 Sep 19;7(9):279. doi: 10.3390/nano7090279

Figure 9.

Figure 9

Biocompatibility of two TiO2/RGO nanocomposites samples (A and B) and commercially available TiO2 NPs (P25), as shown by cell viability assay at 24 and 48 h exposure for normal skin (a,c) and lung (b,d) cells. Data are calculated as means ± standard deviation (SD) (n = 3) and showed relative to control (untreated cells). * p < 0.05 and ** p < 0.01 vs. control.